Description

This episode of the Boston Children’s Hospital Clinical Pathways Podcast explores the development and implementation of the Acne clinical pathway, emphasizing the role primary care clinicians can play in managing this common, chronic condition. Through a dialogue between primary care and dermatology experts, the discussion highlights evidence-based treatment strategies, realistic expectations for therapy, adherence challenges, and the psychosocial impact of acne. The speakers also address emerging topics such as social media influences, treatment equity for patients with skin of color, and safe use of common acne therapies.

Clinical Pathways are educational reference tools developed by Boston Children’s Hospital clinicians which focus on the diagnosis and management of a wide variety of clinical conditions based on up-to-date evidence and expert practice. On this show, host Miya Bernson-Leung, MD, EdM, Medical Director of Continuing Education and a member of the Clinical Pathways Advisory Committee, interviews clinical experts to take you behind each pathway, discussing why the pathway was developed and key takeaways for clinicians seeking to implement the pathway and provide safe, effective, evidence-based care to children. You can find the full library at https://clinical.pathways.childrenshospital.org/.

Any treatment and/or medication recommendations within the pathway is provided for educational reference only, it is not intended as medical advice for individual patient care. Decisions about evaluation, diagnosis, and/or treatment are the responsibility of the patient’s treating clinician and should always be tailored to the individual patient’s clinical care needs.

Learning Objectives:  At the conclusion of this educational program, learners will be able to:

1. Describe evidence-based approaches for the assessment and management of mild, moderate, and severe acne in the primary care setting, including when referral to dermatology is indicated.
2. Apply patient-centered strategies to improve adherence and outcomes in acne treatment, with attention to anticipatory guidance, chronic disease management, psychosocial impact, and considerations for skin of color.

In support of improving patient care, Boston Children’s Hospital is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician

Boston Children’s Hospital designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits ™. Physicians should claim only credit commensurate with the extent of their participation in this activity.

Physician Assistant

Boston Children’s Hospital has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credits for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Nurse

Boston Children’s Hospital designates this activity for 0.75 contact hours for nurses. Nurses should only claim credit commensurate with the extent of their participation in the activity. 

Pharmacy

This activity carries a maximum of 0.75 contact hours. Pharmacists should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Policy 

Boston Children’s Hospital adheres to all ACCME Essential Areas, Standards, and Policies. It is Boston Children’s policy that those who have influenced the content of a CE activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that Boston Children’s may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.

Disclosure Statement

The following planners, speakers, and content reviewers, on behalf of themselves, have reported the following relevant financial relationships with any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on patients: 

Faculty

Joshua Borus, MD, MPH

Director, Medical Student and Resident Training in Adolescent/Young Adult Medicine, Boston Children’s Hospital
Director of Quality Improvement, Boston Children’s Hospital
Attending Physician, Division of Adolescent/Young Adult Medicine, Boston Children’s Hospital
Assistant Professor of Pediatrics, Harvard Medical School

 

 

 

 

Sophia Delano, MD

Dermatologist, Dermatology Program, Boston Children’s Hospital
Director, Quality Improvement and Physician Outreach, Boston Children’s Hospital
Director, Genodermatology, Boston Children’s Hospital
Instructor of Dermatology, Harvard Medical School

 

 

 

 

Moderator: Miya Bernson-Leung, MD, EdM

Program Director, Child Neurology Residency Training Program, Boston Children’s Hospital
Medical Director of Continuing Education, Center for Educational Excellence and Innovation, Boston Children’s Hospital
Assistant Professor of Neurology, Harvard Medical School